US2018228898A1PendingUtilityA1

Conveniently implantable sustained release drug compositions

60
Assignee: RAMSCOR INCPriority: Oct 1, 2004Filed: Mar 28, 2018Published: Aug 16, 2018
Est. expiryOct 1, 2024(expired)· nominal 20-yr term from priority
A61P 39/06A61P 37/06A61P 27/06A61K 31/496A61K 47/06A61K 9/0048A61K 31/573A61K 9/0051A61K 31/355A61K 47/14A61K 38/13A61P 29/00A61K 9/0019A61K 9/0024A61P 31/00
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention provides for biocompatible and biodegradable syringeable liquid, implantable solid, and injectable gel pharmaceutical formulations useful for the treatment of systemic and local disease states.

Claims

exact text as granted — not AI-modified
We claim: 
     
         1 . A method of treating inflammation in an eye of a subject comprising injecting into an anterior chamber of the eye of a subject in need thereof a liquid pharmaceutical composition consisting of a therapeutically effective amount of dexamethasone dispersed in a triethyl ester of O-acetylcitric acid (TEAC). 
     
     
         2 . The method of  claim 1 , wherein the liquid pharmaceutical composition contains about 10% dexamethasone. 
     
     
         3 . The method of  claim 1 , wherein a dosage unit consists of about 200 μg dexamethasone. 
     
     
         4 . The method of  claim 1 , wherein a dosage unit consists of about 400 μg dexamethasone. 
     
     
         5 . A liquid pharmaceutical composition consisting of a therapeutically effective amount of dexamethasone dispersed in a triethyl ester of O-acetylcitric acid (TEAC). 
     
     
         6 . A method of administering the liquid pharmaceutical composition of  claim 5 , comprising injecting the composition into the anterior chamber/anterior segment of the eye of a subject in need thereof. 
     
     
         7 . The method of  claim 6 , wherein the liquid pharmaceutical composition contains about 10% (wy) dexamethasone. 
     
     
         8 . A liquid pharmaceutical composition consisting of about 10% (wt) dexamethasone dispersed in a triethyl ester of O-acetylcitric acid (TEAC). 
     
     
         9 . A method of administering the liquid pharmaceutical composition of  claim 7 , comprising injecting it into the anterior chamber/anterior segment of the eye of a subject in need thereof. 
     
     
         10 . A method of administering the liquid pharmaceutical composition of  claim 8 , comprising injecting it into the anterior chamber/anterior segment of the eye of a subject in need thereof.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.